Valorisation-recherche, Limited Partnership

Universitéde Montreal

Valorisation Hsj, Limited Partnership

Theratechnologies Inc.

Other

University of Ottawa

Rsem, Limited Partnership

William A Lubell

Sylvain Chemtob

Huy Ong

Caroline Proulx

Florian Sennlaub

Damien Boeglin

Zohreh Sajjadi

David Sabatino

Krishna G Peri

Jeffrey W Keillor

Eryk Thouin

Christophe Pardin

Felix Polyak

Juntao Luo

Stephane Alain Laporte

Yesica Garcia-Ramos

Ngoc-Duc Doan

Terence E Hebert

Audrey Claing

Carine B Bourguet

Eugenie Goupil

Xin Hou

Danae Tassy

Julian Xiao-Xia Zhu

Pardin Christophe

Tarek Kassem

Robert Hopewell

Kim Beauregard

An azapeptide compound of Formula I:A-(Xaa)-N(R)&#x2014;N(R)&#x2014;C(O)-(Xaa')-B &#x2003;&#x2003;I.

Azapeptides as CD36 binding compounds

Cinnamoyl inhibitors of transglutaminase

An azapeptide compound of Formula I:A-(Xaa)-N(R)&#x2014;N(R)&#x2014;C(O)-(Xaa')-B&#x2003;&#x2003;I.

The invention relates to compositions which are useful for inhibiting prostaglandin Freceptor. The compositions include, but are not limited to, linear peptides, peptide analogs, and peptidomimetics. Methods of using the compositions of the invention to treat preterm labor and dysmenorrhea are disclosed.

[object Object]

Novel peptidomimetics comprising N-amino cyclic urea residues are disclosed. Use of such peptidomimetics for modulating the activity of CD36 or IL-1 receptor in a cell, and for treating CD36- or IL-1-related disease, disorder or condition is also described.

Peptidomimetics comprising N-amino cyclic urea residues and uses thereof

Prostaglandin-F2 alpha (PGF2&#x3b1;) receptor (FP) modulators of formula I, as well as the use of PGF2&#x3b1; receptor modulators for the treatment of conditions associated with FP activity such as preterm labor and colorectal cancer, are disclosed.

Prostaglandin-F2 alpha receptor modulators and uses thereof

A compound of Formula, (I) or Formula: (II).

An azapeptide derivative of growth hormone releasing peptide (GHRP) of Formula I: A-(Xaa)-N(R)&#x2014;N(R)&#x2014;C(O)-(Xaa')-B which binds to CD 36.

There are provided poly(vinyl alcohol) polymers and copolymers containing vinyl alcohol or vinyl acetate and derivatives thereof such as poly(ethylene glycol)-grafted poly(vinyl alcohol) polymers or polyether-grafted poly(vinyl alcohol) polymers. These polymers can contain various functional groups. Such polymers can be use as polymer matrix or solid support for various chemical substrates such as organic substrates and reagents. Cross-linked poly(vinyl alcohol) polymers and copolymers are also provided. Methods for preparing such polymers as well as several of their uses are also included.

Poly (vinyl alcohol) polymers, uses and preparation thereof

Growing community of inventors

Montréal, Canada

William A Lubell